Perdix 7.5mg tablets

Land: Storbritannia

Språk: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiv ingrediens:

Moexipril hydrochloride

Tilgjengelig fra:

UCB Pharma Ltd

ATC-kode:

C09AA13

INN (International Name):

Moexipril hydrochloride

Dosering :

7.5mg

Legemiddelform:

Oral tablet

Administreringsrute:

Oral

Klasse:

No Controlled Drug Status

Resept typen:

Valid as a prescribable product

Produkt oppsummering:

BNF: 02050501; GTIN: 5015366085320

Informasjon til brukeren

Note:
Artwork Studio checks and approves technical accuracy and pre-press
suitability of this artwork only. Ensure the artwork has been
thoroughly
checked for textual accuracy and has been approved as such!
Aesica Pharmaceuticals GmbH
Packaging Technology & Artwork Services
Alfred-Nobel-Straße 10
40789 Monheim, Germany
Artwork Studio
Date
Operator
Approver
PT Approval
Dispatched to
Schlüter
Manufacturing Site
Artwork Information
Fontsize Bodytext
8 pt
Linespacing
9 pt
Technical Changes
MOCK-UP
Product Name
Perdix
Print Colours
Techn. Colours
Aesica Id.-No.
/ GBR
black
external Id.-No.
CIA77361A_MU3
Dimensions
140 x 520 mm
Operator
Peggy Nathaus
Creation Date
03.12.2014
Amended by
Peggy Nathaus
Modific. Date
16.012.2014
Edition No.
02
VPT-Pool/Technik/ABV_SOP_Vorgaben/Freigabefeld/Freigabefeld_Aesica_08/2011
PACKAGE LEAFLET:
INFORMATION FOR THE PATIENT
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it
again.
•
If you have any further questions, ask your
doctor or pharmacist.
•
This medicine has been prescribed for you
only. Do not pass it on to others. It may harm
them, even if their signs of illness are the
same as yours.
•
If you get any side effects, talk to your doctor
or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Perdix is and what it is used for
2. What you need to know before you take
Perdix
3. How to take Perdix
4. Possible side effects
5. How to store Perdix
6. Content of the pack and other information
CIA77361A_MU3 10/145 1168
PERDIX
®
7.5
MG
FILM-COATED TABLETS
PERDIX
®
15
MG
FILM-COATED TABLETS
Moexipril hydrochloride
1. WHAT PERDIX IS AND WHAT IT IS USED FOR
Perdix belongs to a group of medicines called
“ACE inhibitors”.
It works by blocking the effect of a substance
called angiotensin-converting enzyme. This
enzyme is important in the control of blood
pressure. Perdix is used to treat

Preparatomtale

OBJECT 1
PERDIX 7.5 MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 25-Sep-2015 | UCB Pharma
Limited
1. Name of the medicinal product
Perdix 7.5 mg film-coated tablets
2. Qualitative and quantitative composition
Each Perdix 7.5 mg tablet contains moexipril hydrochloride 7.5 mg.
Excipients:
Each tablet contains 71 mg lactose monohydrate.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablet.
Each Perdix 7.5 mg tablet is pink, round, convex, with a break line
above and marked SP/7.5 on the upper
side and 707 on the lower side.
The tablet can be divided into equal halves.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of hypertension as monotherapy in adult patients.
As second line therapy for the treatment of hypertension in
combination with diuretics or calcium
antagonists e.g. hydrochlorothiazide or nifedipinein adult patients.
4.2 Posology and method of administration
_General:_
Perdix should be administered orally in a single daily dose. As with
all other medicinal products taken
once daily, it should be taken at approximately the same time each day
in the morning before having any
food, best immediately upon waking. The absorption of Perdix is
affected by food. Therefore it should be
taken before food (see also section 5.2).
_Initial therapy:_
In patients with uncomplicated essential hypertension not on diuretic
therapy, the recommended initial
dose is 7.5 mg once a day. Dosage should be adjusted according to
blood pressure response. The
maintenance dose is 7.5 to 15 mg moexipril daily, administered in a
single dose. Some patients may
benefit from a further increase to 30 mg per day.
Doses over 30 mg have been used, but do not appear to give a greater
effect.
If blood pressure is not controlled with Perdix alone, a low dose of a
diuretic may be added.
Hydrochlorothiazide 12.5 mg has been shown to provide an additive
effect. With concomitant diuretic
therapy, it may be possible to reduce the dose of Perdix.
_Diuretic treated patients:_